Research Article
Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease
Table 2
Serum fatty acids and biochemical markers by ADMA quartiles and in the upper decile of plasma ADMA concentration1.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALA: α-linolenic acid; ApoA1: apolipoprotein A-I; Ch: cholesterol; CRP: C-reactive protein; DHA: docosahexaenoic acid; DPA: docosapentaenoic acid; EPA: eicosapentaenoic acid; GFR: glomerular filtration rate; HbA1c: hemoglobin A1c; HDL: high density lipoprotein; LDL: low density lipoprotein; Lp(a): lipoprotein(a); n-3 PUFAs: omega-3 polyunsaturated fatty acids; TFAs: total fatty acids; TG: triglycerides; n-3 LCPUFAs: long chain omega-3 polyunsaturated fatty acids; wt%: percentage by weight. 1Median (range) plasma ADMA concentrations (μmol/L) are presented. For fatty acids, lipid related parameters, and other parameters; mean (95% confidence interval) values are given after adjustment for age (continuous) and sex. 2P trend by linear regression adjusting for age (continuous), sex, acute coronary syndrome (yes/no), and statin treatment at baseline (yes/no). 3Combination of ALA, EPA, DPA, and DHA. 4Combination of EPA, DPA, and DHA. |